Talk:Prostatitis
{{talkheader}}
{{Reliable sources for medical articles}}
{{WikiProject banner shell |class=C |1=
{{WikiProject Medicine|importance=Mid}}
}}
{{User:MiszaBot/config
| algo=old(90d)
| archive= Talk:Prostatitis/Archive %(counter)d
| counter = 5
| maxarchivesize = 200K
| archiveheader = {{Automatic archive navigator}}
| minthreadsleft = 2
| minthreadstoarchive = 1
}}
Mentioning type III etiology controversy?
{{Ping|Ratel}} Do you think we can add somewhere in the article about the controversy and discordance of type III etiology? There is this review article that mentions this in the section "2.3.1.Etiology and pathogenesis"
- {{Cite journal |last=Khan |first=Farhan Ullah |last2=Ihsan |first2=Awais Ullah |last3=Khan |first3=Hidayat Ullah |last4=Jana |first4=Ruby |last5=Wazir |first5=Junaid |last6=Khongorzul |first6=Puregmaa |last7=Waqar |first7=Muhammad |last8=Zhou |first8=Xiaohui |date=2017 |title=Comprehensive overview of prostatitis |url=https://linkinghub.elsevier.com/retrieve/pii/S0753332217319418 |journal=Biomedicine & Pharmacotherapy |issn=0753-3322 |language=en |volume=94 |pages=1064–1076 |doi=10.1016/j.biopha.2017.08.016 | pmid=28813783}}
—Arthurfragoso (talk) 00:12, 29 June 2019 (UTC)
::Some points:
::# Although a review article, the journal you cite has a SJR of less than 1. So not a great journal.
::# The study comes from obscure centers in China and Pakistan. Wikipedia would not accept novel insights or claims of "controversy" from such sources without corroboration from other sources.
::There are much better sources available discussing the difficulties with Cat. III etiology. Ratel (talk) 03:57, 29 June 2019 (UTC)